N/A N=81 Randomized Single-blind Supportive Care

Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief

Pain

Bottom Line

View on ClinicalTrials.gov: NCT00919100 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2018

Primary outcome: Primary: Faces Pain Scale-Revised (FPS-R) — 4; 2 units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Buzzy (Device); vapocoolant (Other)
Age: Pediatric, Adult · 4+ yrs
Sex: All
Sponsor: Georgia State University
Primary completion: Aug 2008

Outcome Measures

Outcome	Result	p-value
PRIMARY Faces Pain Scale-Revised (FPS-R)	4; 2	—
SECONDARY OSBD-R Observational Pain/Distress Scale	2; 1	—
SECONDARY Number of Participants With Venipuncture Success in One Attempt	26; 35	—

Summary

A vibrating cold pack placed proximal to the site of venipuncture will decrease the pain of cannulation when compared to vapocoolant spray.

Eligibility Criteria

Inclusion Criteria

Patients requiring venipuncture in a pediatric emergency department
Informed consent
Patient assent

Exclusion criteria

Patients with sickle cell or other sensitivity to cold
Nerve damage in the area
Abrasion or break in skin where device would be placed
Critically ill

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00919100). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.